Published in Trends Microbiol on April 16, 2013
Microbial communities in the respiratory tract of patients with interstitial lung disease. Thorax (2013) 1.08
Polybacterial human disease: the ills of social networking. Trends Microbiol (2014) 1.01
The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography. Am J Respir Crit Care Med (2014) 1.00
Respiratory microbiota: addressing clinical questions, informing clinical practice. Thorax (2014) 0.98
Ecological theory as a foundation to control pathogenic invasion in aquaculture. ISME J (2014) 0.97
Shifting the paradigm from pathogens to pathobiome: new concepts in the light of meta-omics. Front Cell Infect Microbiol (2014) 0.96
Redefining the Chronic-Wound Microbiome: Fungal Communities Are Prevalent, Dynamic, and Associated with Delayed Healing. MBio (2016) 0.94
Toward making inroads in reducing the disparity of lung health in Australian indigenous and new zealand māori children. Front Pediatr (2015) 0.78
Phylogenetics and the human microbiome. Syst Biol (2014) 0.78
Predominant pathogen competition and core microbiota divergence in chronic airway infection. ISME J (2014) 0.77
The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance. Ann Epidemiol (2016) 0.76
Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa. PLoS One (2017) 0.75
Electrochemical detection of Pseudomonas in wound exudate samples from patients with chronic wounds. Wound Repair Regen (2016) 0.75
Republished: Respiratory microbiota: addressing clinical questions, informing clinical practice. Postgrad Med J (2015) 0.75
The microbiota of water buffalo milk during mastitis. PLoS One (2017) 0.75
How can the cystic fibrosis respiratory microbiome influence our clinical decision-making? Curr Opin Pulm Med (2017) 0.75
Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med (2003) 9.78
Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell (2006) 9.64
The merging of community ecology and phylogenetic biology. Ecol Lett (2009) 5.98
Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol (2012) 5.35
Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One (2011) 4.65
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38
The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22
Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A (2007) 4.06
Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A (2012) 3.43
Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One (2010) 3.38
The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 3.36
Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med (2010) 3.36
The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol (2011) 3.13
A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput Biol (2013) 2.96
'Everything is everywhere, but, the environment selects'; what did Baas Becking and Beijerinck really say? Environ Microbiol (2006) 2.79
Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol (2010) 2.55
Phylogenetic analysis of community assembly and structure over space and time. Trends Ecol Evol (2008) 2.55
Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME J (2010) 2.55
Fundamentals of microbial community resistance and resilience. Front Microbiol (2012) 2.53
Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci U S A (2012) 2.22
Human microbiome in health and disease. Annu Rev Pathol (2011) 2.18
Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol (2006) 2.14
Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog (2008) 2.09
Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med (2013) 2.08
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One (2012) 2.03
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J (2011) 1.83
Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol (2012) 1.70
Shifts in human skin and nares microbiota of healthy children and adults. Genome Med (2012) 1.58
Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection. Proc Natl Acad Sci U S A (2012) 1.51
Biogeography of the ecosystems of the healthy human body. Genome Biol (2013) 1.48
Reducing bias in bacterial community analysis of lower respiratory infections. ISME J (2012) 1.46
Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med (2012) 1.40
Convergent temporal dynamics of the human infant gut microbiota. ISME J (2009) 1.31
Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. Curr Pharm Biotechnol (2002) 1.30
Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis. J Cyst Fibros (2012) 1.14
Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax (2012) 1.07
Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy. Int J Med Microbiol (2010) 0.97
Microbial transformation from normal oral microbiota to acute endodontic infections. BMC Genomics (2012) 0.97
Pathogenesis of bronchiectasis. Paediatr Respir Rev (2010) 0.93
Fitness landscape of antibiotic tolerance in Pseudomonas aeruginosa biofilms. PLoS Pathog (2011) 0.90
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A (2006) 8.85
Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol (2007) 2.87
Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME J (2010) 2.55
Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med (2010) 2.40
Asymmetrical distribution of the second messenger c-di-GMP upon bacterial cell division. Science (2010) 1.99
Bacterial activity in cystic fibrosis lung infections. Respir Res (2005) 1.74
Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes. Am J Respir Crit Care Med (2014) 1.66
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? J Cyst Fibros (2011) 1.53
Reducing bias in bacterial community analysis of lower respiratory infections. ISME J (2012) 1.46
Studying bacterial infections through culture-independent approaches. J Med Microbiol (2009) 1.38
Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections. Diagn Microbiol Infect Dis (2008) 1.34
Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis. Clin Infect Dis (2013) 1.34
Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers. J Clin Microbiol (2010) 1.32
Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax (2013) 1.28
Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol (2010) 1.24
Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity. Expert Rev Mol Diagn (2010) 1.24
Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches. BMC Pulm Med (2009) 1.22
Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients. J Bacteriol (2012) 1.20
A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Ann Am Thorac Soc (2014) 1.17
The cystic fibrosis airway microbiome. Cold Spring Harb Perspect Med (2013) 1.14
Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling. J Clin Microbiol (2009) 1.13
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy. Trends Microbiol (2010) 1.01
Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action. Eur Biophys J (2011) 1.01
Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota. Ann Am Thorac Soc (2014) 0.97
Comparing the microbiota of the cystic fibrosis lung and human gut. Gut Microbes (2010) 0.97
TRPV1 deletion enhances local inflammation and accelerates the onset of systemic inflammatory response syndrome. J Immunol (2012) 0.95
Enhancing the utility of existing antibiotics by targeting bacterial behaviour? Br J Pharmacol (2012) 0.88
Ascitic microbiota composition is correlated with clinical severity in cirrhosis with portal hypertension. PLoS One (2013) 0.88
Comparison of the distal gut microbiota from people and animals in Africa. PLoS One (2013) 0.87
Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol (2007) 0.87
Bacterial community diversity in cultures derived from healthy and inflamed ileal pouches after restorative proctocolectomy. Inflamm Bowel Dis (2009) 0.86
Molecular microbiological characterization of preterm neonates at risk of bronchopulmonary dysplasia. Pediatr Res (2010) 0.86
Three clinically distinct chronic pediatric airway infections share a common core microbiota. Ann Am Thorac Soc (2014) 0.85
Is there an association between microbial exposure and food allergy? A systematic review. Pediatr Allergy Immunol (2013) 0.84
Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum. Respir Res (2009) 0.84
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis. J Cyst Fibros (2011) 0.84
Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions. Antimicrob Agents Chemother (2013) 0.84
Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application. Mol Diagn Ther (2010) 0.83
Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother (2010) 0.83
Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy. J Pharm Sci (2008) 0.83
The use of culture-independent tools to characterize bacteria in endo-tracheal aspirates from pre-term infants at risk of bronchopulmonary dysplasia. J Perinat Med (2010) 0.82
Is there a case for n-3 fatty acid supplementation in cystic fibrosis? Curr Opin Clin Nutr Metab Care (2005) 0.82
Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesia. J Clin Microbiol (2013) 0.82
Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset. Expert Rev Mol Diagn (2011) 0.81
Heterogeneous selection in a spatially structured environment affects fitness tradeoffs of plasmid carriage in pseudomonads. Appl Environ Microbiol (2008) 0.81
Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome. Mamm Genome (2015) 0.80
Did bacterial sensing of host environments evolve from sensing within microbial communities? Cell Host Microbe (2007) 0.79
Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients. Diagn Microbiol Infect Dis (2009) 0.79
Determining the effects of a spatially heterogeneous selection pressure on bacterial population structure at the sub-millimetre scale. Microb Ecol (2010) 0.78
The pediatric microbiome and the lung. Curr Opin Pediatr (2015) 0.77
Emerging drugs for bronchiectasis. Expert Opin Emerg Drugs (2012) 0.76
Exploring the parallel development of microbial systems in neonates with cystic fibrosis. MBio (2012) 0.75
Evaluation of a rapid lateral flow immunoassay for Staphylococcus aureus detection in respiratory samples. Diagn Microbiol Infect Dis (2012) 0.75
Emerging drugs for bronchiectasis: an update. Expert Opin Emerg Drugs (2015) 0.75
Clinical application of direct sputum sensitivity testing in a severe infective exacerbation of cystic fibrosis. Pediatr Pulmonol (2003) 0.75
How can the cystic fibrosis respiratory microbiome influence our clinical decision-making? Curr Opin Pulm Med (2017) 0.75